Yi J. Gao

197 Ruijin Road No.2
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications

Correction: The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.

Correction: The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.

Journal: Medical oncology (Northwood, London, England)
Published: July 28, 2026

A stratified urine-based molecular diagnostic and prognostic model for non-muscle-invasive bladder cancer management.

A stratified urine-based molecular diagnostic and prognostic model for non-muscle-invasive bladder cancer management.

Journal: BMC cancer
Published: January 22, 2026

Urine-Based Biomarkers in the Diagnosis of Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.

Urine-Based Biomarkers in the Diagnosis of Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.

Journal: Journal of clinical medicine
Published: December 30, 2025

Application of three-anatomical-plane dissection technique in the partial nephrectomy of renal cell carcinoma abutting the hilum gulf.

Application of three-anatomical-plane dissection technique in the partial nephrectomy of renal cell carcinoma abutting the hilum gulf.

Journal: World journal of surgical oncology
Published: August 30, 2025

Correction: Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma.

Correction: Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma.

Journal: Cell death & disease
Published: May 19, 2025

Nuclear receptors as novel regulators that modulate cancer radiosensitivity and normal tissue radiotoxicity.

Nuclear receptors as novel regulators that modulate cancer radiosensitivity and normal tissue radiotoxicity.

Journal: Molecular cancer
Published: April 15, 2025

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: Protocol for a Pilot Randomized Controlled Trial.

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: Protocol for a Pilot Randomized Controlled Trial.

Journal: JMIR research protocols
Published: February 13, 2025

Oncometabolite fumarate facilitates PD-L1 expression and immune evasion in clear cell renal cell carcinoma.

Oncometabolite fumarate facilitates PD-L1 expression and immune evasion in clear cell renal cell carcinoma.

Journal: Cell death & disease
Published: February 08, 2025

Comparative evaluation of SanAgileTMSA01 ultrasonic scalpel and Johnson & Johnson GEN11, and HAR36 for efficacy and safety.

Comparative evaluation of SanAgileTMSA01 ultrasonic scalpel and Johnson & Johnson GEN11, and HAR36 for efficacy and safety.

Journal: Expert review of medical devices
Published: December 11, 2024

BBOX1 Is a Metabolic Checkpoint That Mediates Metastatic Cancer Cell Evasion from Immunosurveillance by NK Cells.

BBOX1 Is a Metabolic Checkpoint That Mediates Metastatic Cancer Cell Evasion from Immunosurveillance by NK Cells.

Journal: Cancer research
Published: November 26, 2024

mTOR Inhibitor Everolimus Modulates Tumor Growth in Small-Cell Carcinoma of the Ovary, Hypercalcemic Type and Augments the Drug Sensitivity of Cancer Cells to Cisplatin.

mTOR Inhibitor Everolimus Modulates Tumor Growth in Small-Cell Carcinoma of the Ovary, Hypercalcemic Type and Augments the Drug Sensitivity of Cancer Cells to Cisplatin.

Journal: Biomedicines
Published: November 13, 2024

Targeting on the PI3K/mTOR: a potential treatment strategy for clear cell ovarian carcinoma.

Targeting on the PI3K/mTOR: a potential treatment strategy for clear cell ovarian carcinoma.

Journal: Cancer chemotherapy and pharmacology
Published: October 09, 2024
Showing 1-12 of 78

Last Updated: 09/26/2026